IL17A and neoplasm: rIL-17A notably enhanced the in vitro production of IL-1β and IL-23 by primary keratinocytes at both the mRNA (Figure 9D) and protein (Figure 9E) levels, suggesting that IL-17A is an important factor to enhance epidermal IL1/23 production in the epidermis around wounds after skin injury.